Counterpoint Mutual Funds LLC Reduces Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Counterpoint Mutual Funds LLC lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 43.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 78,668 shares of the pharmacy operator’s stock after selling 60,154 shares during the quarter. Counterpoint Mutual Funds LLC’s holdings in Walgreens Boots Alliance were worth $734,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. First Financial Corp IN raised its holdings in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $26,000. Riverview Trust Co increased its stake in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares during the period. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $28,000. Finally, TD Private Client Wealth LLC lifted its holdings in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.3 %

WBA stock opened at $11.23 on Monday. The business has a 50-day moving average of $10.83 and a 200-day moving average of $9.76. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The stock has a market capitalization of $9.70 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.66 earnings per share. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on WBA shares. Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Evercore ISI raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Bank of America upped their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.